TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Morning stiffness severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-leg standing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Affect (NA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the plasma concentration-time curve (AUC0–∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: events of hyperthermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with education
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Full-time employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Global clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak adrenergic symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported hypoglycemia awareness (Gold score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time spent <3.9 and <3.0 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DIAGNOdent pen scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term cognitive decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of ADRD or MCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of severe infection
Endpoint domain: Adverse events/effects
Primary endpoint: Time-to-fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tube insertion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-information ST AI-S scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of GK technology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive RT-PCR test results for COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Time of cough disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FeNO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EOS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Hamilton Depression Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number-needed-to-treat (NNT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in tongue microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in relative abundance of Prevotella and Porphyromonas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Firmicutes/Bacteroidetes ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary system outcomes
Primary endpoint: Reduction in AST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary system outcomes
Primary endpoint: mean ccIMT change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: delirium rate
Endpoint domain: Mortality/survival
Primary endpoint: Suture closure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SBSES scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IV catheter insertion performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction and self-confidence scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Impaired glucose homoeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased intestinal endotoxin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increased systemic inflammation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VAP ratio per 1000 ventilation days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Success rate (SFR) at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in negative schematic beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reductions in delusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reductions in imagery distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative Incidence of Local Recurrence (LRR)
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative Incidence of Distant Recurrence (DR)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in clicking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved eating disorder‐related quality of life (EDQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FM scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased relative delta power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased relative alpha power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ACE detected by cerebral MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SVHI‐10 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of ISSI
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of excessive scarring
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of umbilical hernia
Endpoint domain: Adverse events/effects
Primary endpoint: Risky option choice frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of intraoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early postvitrectomy hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early visual recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fatigue outcomes
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cardiac sympathovagal balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of DL vs F-F approach in suturing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Student acceptance of DL approach
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: student motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: psychomotor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastrocnemius stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sedentary Time (SST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor response to CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in the width of the widest striae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in epidermal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of maximum heart rate (%HR max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Loss of body fluids (LBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived fatigue (RPE)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in miRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of enzymes involved in myocardial pre- and postconditioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in cell apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes distress-related knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence to provide support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: asking behaviours
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: incidence of adverse events graded 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Thickness of the CHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Thickness of the CAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of first adjudicated serious fall injury
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of first participant-reported fall injury
Endpoint domain: Adverse events/effects
Primary endpoint: SAME
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores when coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum calcium decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: iPTH increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: iFGF23 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: postoperative Visual Analogue Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meibomian gland secretion function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: main adverse cardiac and cerebrovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Inhibition of T-lymphocyte proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cumulative disease scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General wound appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Suicidal ideation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD core symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in ureteral luminal circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of predicted REE increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of fat-free mass increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ablation injury to the esophageal mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PLM ∆peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Need for follow-up after support
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: screw insertion suitability rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: stabilization suitability rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: eligibility rate for stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: pain interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: proportion of patients in remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 8‐isoprostane levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission to hospital
Endpoint domain: Mortality/survival
Primary endpoint: In-hospital prescription changes not maintained by PCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Insomnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MACE occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive score based on BSID-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety/depression score based on CBCL
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: elevated sodium concentration in tumours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: classification accuracy of tumour vs non‐tumour regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biomarker of treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrepant rapid test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of fully immunized children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete ulcer closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: P1 amplitude of mfERG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IS risk based on telomere lengths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease SLNB rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: daily urinary output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: histological complete response of the primary tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: average daily calcium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: likelihood of vitamin D supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TUG time score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood leukocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mTICI grade 2a-3 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day modified Rankin Scale ≤ 2 or improvement of NIH Stroke Scale ≥ 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of times postural threshold was exceeded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding recurrence at day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day bleeding recurrence-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 5-year ECSS
Endpoint domain: Mortality/survival
Primary endpoint: mean percent vital bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of residual graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative opioid agents dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postanesthesia care unit recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signing the donor card
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Bone fusion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction of NPRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic exposure of bismuth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery score (QoR-15)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Postoperative Nausea and Vomiting (PONV)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first required rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of sedentary time (SB%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total physical activity (TPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in speech perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eating disorder symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of primary outcome in patients
Endpoint domain: Mortality/survival
Primary endpoint: Expression levels of MMP-2 and TIMP-2 in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of α-SMA, type I and type III collagen in gingival tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-cesarean pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of pethidine hydrochloride
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Consumption of paracetamol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: EEG power in the alpha1 frequency band (8–10 Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nutrition behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical application skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inadequate physical activity at five years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically-important fatigue at five years
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Excessive sedentary behaviour at five years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whitening effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BS intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain associated with sling use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concerns regarding surgical repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Environmental QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: General QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QoL satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Progression of the Correa score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of self‐rating anxiety scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scores of self‐rating depression scale (SDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maintained/improved 30‐second Chair Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titers of OPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportions of patients reaching OPA cut-off
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: push out bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of antimicrobial use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: theoretical and practical scores on prevention and treatment of pressure sore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction degree scores for training mode, curriculum design, and training effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: best visual results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of dystrophic hairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PanCan accuracy for assessing cancer in solid lung nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes